New patent for Intra-cellular drug CAPLYTA

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug. CAPLYTA drug price trends.…
The post New patent for Intra-cellular drug CAPLYTA appeared fi…


Which pharmaceutical drugs have the most drug patents in Portugal?

This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Portug…


Biotechblog